KB Financial Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$143K Sell
918
-580
-39% -$95.7K 0.04% 173
2023
Q2
$248K Sell
1,498
-3,153
-68% -$509K 0.07% 164
2023
Q1
$721K Sell
4,651
-65
-1% -$10.5K 0.21% 52
2022
Q4
$833K Buy
4,716
+3
+0.1% +$518 0.28% 41
2022
Q3
$770K Buy
4,713
+574
+14% +$97.1K 0.28% 37
2022
Q2
$735K Sell
4,139
-771
-16% -$137K 0.25% 36
2022
Q1
$870K Buy
4,910
+213
+5% +$36.2K 0.24% 34
2021
Q4
$804K Buy
4,697
+70
+2% +$11.5K 0.23% 35
2021
Q3
$747K Buy
4,627
+316
+7% +$53.9K 0.27% 33
2021
Q2
$710K Sell
4,311
-94
-2% -$15.6K 0.27% 30
2021
Q1
$724K Buy
+4,405
New +$713K 0.31% 31

Other funds holding JNJ

KB Financial Partners's JNJ Position: Q3 2023 in Review

KB Financial Partners reduced its Johnson & Johnson (JNJ) stake by 39% in Q3 2023, selling an estimated $95.7K and leaving 918 shares worth $143K. The position accounts for 0.04% of the portfolio, ranked #173.

KB Financial Partners first reported a position in JNJ in Q1 2021 and has held it in 11 quarters since. The position peaked at $870K in Q1 2022. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • KB Financial Partners held 918 shares of Johnson & Johnson worth $143K as of Q3 2023.
  • KB Financial Partners sold 580 Johnson & Johnson shares in Q3 2023, an estimated $95.7K.
  • Johnson & Johnson made up 0.04% of KB Financial Partners's portfolio in Q3 2023, its #173 holding.
  • KB Financial Partners first reported a position in Johnson & Johnson in Q1 2021 and has held it in 11 quarters since.
  • KB Financial Partners's Johnson & Johnson position peaked at $870K in Q1 2022.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.